Anger at US deal for Moderna’s ‘taxpayer-funded’ COVID-19 vaccineThe US government has signed another big coronavirus vaccine supply deal, snapping up 100 million doses of Moderna’s Share XAnger at US deal for Moderna’s ‘taxpayer-funded’ COVID-19 vaccinehttps://pharmaphorum.com/news-market-access/anger-at-us-deal-for-modernas-taxpayer-funded-covid-19-vaccine/
Moderna gets further $472m as expanded phase 3 COVID-19 trial beginsA US government agency is to give a further $472 million to biotech Moderna, after it announced plans Share XModerna gets further $472m as expanded phase 3 COVID-19 trial beginshttps://pharmaphorum.com/news/moderna-gets-further-472m-as-expanded-phase-3-covid-19-trial-begins/
Controversy as pharma execs predict profits from COVID-19 vaccinesConcerns have emerged about access to some potential COVID-19 vaccines after pharma executives from three companies said they Share XControversy as pharma execs predict profits from COVID-19 vaccineshttps://pharmaphorum.com/news/controversy-as-pharma-execs-predict-profits-from-covid-19-vaccines/
Moderna’s $37B market cap is too high, despite COVID-19 vaccine; analystJP Morgan has downgraded its valuation of Moderna, saying its $37 billion market cap is way too high Share XModerna’s $37B market cap is too high, despite COVID-19 vaccine; analysthttps://pharmaphorum.com/news/modernas-37b-market-cap-is-too-high-despite-covid-19-vaccine-analyst/
Hot shots named in Trump’s Warp Speed drive for coronavirus vaccinePresident Donald Trump’s Operation Warp Speed, which aims to make a coronavirus vaccine widely available by year-end, has Share XHot shots named in Trump’s Warp Speed drive for coronavirus vaccinehttps://pharmaphorum.com/news/hot-shots-named-in-trumps-warp-speed-drive-for-coronavirus-vaccine/
Expert ‘optimistic’ over COVID-19 vaccines after Moderna data revealThere are reasons to be optimistic over the cutting-edge mRNA vaccines being developed to end the COVID-19 pandemic, Share XExpert ‘optimistic’ over COVID-19 vaccines after Moderna data revealhttps://pharmaphorum.com/news/expert-optimistic-over-mrna-vaccines-for-covid-19/
Moderna to raise $1.34bn for late-stage COVID-19 vaccine trialModerna’s COVID-19 vaccine has produced a strong immune response in early trials – but will it be able to Share XModerna to raise $1.34bn for late-stage COVID-19 vaccine trialhttps://pharmaphorum.com/news/moderna-to-raise-1-34bn-for-late-stage-covid-19-vaccine-trial/
Doubts over US government plans for COVID-19 vaccineThere are doubts about the US government’s plans to have 300 million COVID-19 vaccine doses ready by the Share XDoubts over US government plans for COVID-19 vaccinehttps://pharmaphorum.com/news/doubts-over-us-government-plans-for-covid-19-vaccine/
Sixth COVID-19 vaccine clinical trial begins at UK’s Oxford UniversityThe UK government is throwing £42.5 million at two potential coronavirus vaccine candidates as it steps up efforts Share XSixth COVID-19 vaccine clinical trial begins at UK’s Oxford Universityhttps://pharmaphorum.com/news/sixth-coronavirus-vaccine-trial-begins-at-uks-oxford-university/
